Geneva Partners »

SPDR S&P Biotech shares owned by Geneva Partners

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Geneva Partners from 13F filings

Historical chart of Geneva Partners investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Geneva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Geneva Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.1M 75k 121.93

More positions owned by Geneva Partners

Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Spdr Gold Tr Gold Shs (GLD)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Palantir Technologies Cl A (PLTR)
Vanguard World Health Car Etf (VHT)
Amazon (AMZN)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Series Trust State Street Spd (XBI)
Micron Technology (MU)
Mastercard Cl A (MA)

View all positions for Geneva Partners

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
Susquehanna International
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Deep Track Capital
Jane Street
Citadel Advisors
UBS Group
Millennium Management
Point72 Asset Management
Peak6
Wells Fargo & Company
Soleus Capital Management
Barclays

View all funds holding SPDR S&P Biotech